ÂÜÀòÂÒÂ×

Lynn Neilson has a diverse work experience in the fields of scientific communications, medical writing, research services, and academia. Most recently, they have been serving as the Director of Scientific Communications and Publications at Geron Corporation since January 2024. Prior to that, they worked at Kite Pharma as an Associate Director of Scientific Communications - Global Publications from November 2022 to December 2023. Lynn also served as the Director of Medical Writing at Sierra Oncology from July 2021 to November 2022. Before transitioning to the pharmaceutical industry, they worked at UPMC Health Plan as a Program Administrator of Value-Based Pharmacy Initiatives from April 2018 to July 2021. Lynn's earlier experience includes serving as the Assistant Director for Research Services at UPMC Hillman Cancer Center from January 2008 to March 2018 and as an Adjunct Associate Professor at Point Park University in 2015. Lynn also worked as a Post-doctoral Fellow at Thomas Jefferson University from August 2007 to January 2008.

Lynn Neilson holds a Ph.D. in Tumor Biology from Georgetown University, which they obtained between 2002 and 2007. Prior to that, they earned a B.S. in Biochemistry and Molecular Biology from Penn State University, from 1998 to 2002. Additionally, they have obtained the certification of a Board Certified Medical Affairs Specialist (BCMAS) from the Accreditation Council for Medical Affairs (ACMA) in 2022.